Irisin in patients with nonalcoholic fatty liver disease
Stergios A. Pοlyzos(Aristotle University of Thessaloniki), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Athanasios D. Anastasilakis(Military Hospital), Eleni Geladari(Beth Israel Deaconess Medical Center), Јannis Kountouras(Aristotle University of Thessaloniki)
Cited by 216
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k